LONP1
protein-codinglon peptidase 1, mitochondrial, the group of Serine proteases|AAA ATPases
Gene summary
This gene encodes a mitochondrial matrix protein that belongs to the Lon family of ATP-dependent proteases. This protein mediates the selective degradation of misfolded, unassembled or oxidatively damaged polypeptides in the mitochondrial matrix. It may also have a chaperone function in the assembly of inner membrane protein complexes, and participate in the regulation of mitochondrial gene expression and maintenance of the integrity of the mitochondrial genome. Decreased expression of this gene has been noted in a patient with hereditary spastic paraplegia (PMID:18378094). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2013]
- PRSS15
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010717
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010879
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0005711
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0010879
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010879
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010879
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0010879
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0004675
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0010879
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0005711
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009723
Submitter: ClinGen
The relationship between LONP1 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of December 16, 2020. The LONP1 gene encodes a mitochondrial protease with important roles in proteostasis. The LONP1 gene has been reported only once in relation to autosomal recessive Leigh syndrome spectrum, in 2018 (PMID: 29518248). However, defects of this gene are also associated with other mitochondrial phenotypes outside the scope of the Leigh syndrome spectrum gene-disease curation, including CODAS syndrome (cerebral, ocular, dental, auricular, and skeletal anomalies). Evidence supporting the relationship between LONP1 and Leigh syndrome spectrum includes case-level data and experimental data. This curation included two variants identified in one case in one publication (PMID: 29518248). No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by expression and animal models (PMIDs: 18853439, 32521756). In summary, there is limited evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on December 16, 2020 (SOP Version 7).
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LONP1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004793.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 296 | 29 | 328 | ||
| missense | 5 | 10 | 368 | 166 | 10 | 559 |
| nonsense | 2 | 2 | 5 | 9 | ||
| start loss | 0 | |||||
| frameshift | 4 | 8 | 3 | 15 | ||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 10 | 13 | ||
| Total | 12 | 22 | 389 | 462 | 39 | 924 |
Highest pathogenic variant AF is 0.00004021707
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004784.2 | 18 | MANE Select | |
| Ensembl | ENSP00000353826.2 | 18 | MANE Select | |
| RefSeq | NP_001263408.1 | 19 | Standard | |
| RefSeq | NP_001263409.1 | 16 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- mitochondrial genome maintenance
- response to hypoxia
- protein quality control for misfolded or incompletely synthesized proteins
- mitochondrion organization
- aging
Molecular Function
- mitochondrial promoter sequence-specific DNA binding
- single-stranded DNA binding
- single-stranded RNA binding
- ATP-dependent peptidase activity
- serine-type endopeptidase activity
Cellular Component
- nucleus
- nucleoplasm
- mitochondrion
- mitochondrial matrix
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000360614
- Coding exons
- 18
- Length
- 28739
- Individuals with no LoFs
- 125736
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 8
- Defined
- 125744
- p
- 0.0000318
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.428 | 605 | 635 | 0.952 | 0.0000431 | 6172 |
| Missense (PolyPhen) | 178 | 242.17 | 0.73504 | 2277 | ||
| Synonymous | -4.80 | 404 | 298 | 1.35 | 0.0000229 | 1982 |
| Loss of Function | 5.37 | 5 | 43.0 | 0.116 | 0.00000210 | 493 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000036 | 0.000035 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: ATP-dependent serine protease that mediates the selective degradation of misfolded, unassembled or oxidatively damaged polypeptides as well as certain short-lived regulatory proteins in the mitochondrial matrix. May also have a chaperone function in the assembly of inner membrane protein complexes. Participates in the regulation of mitochondrial gene expression and in the maintenance of the integrity of the mitochondrial genome. Binds to mitochondrial promoters and RNA in a single- stranded, site-specific, and strand-specific manner. May regulate mitochondrial DNA replication and/or gene expression using site- specific, single-stranded DNA binding to target the degradation of regulatory proteins binding to adjacent sites in mitochondrial promoters (PubMed:12198491, PubMed:15870080, PubMed:17420247, PubMed:8248235). Endogenous substrates include mitochondrial steroidogenic acute regulatory (StAR) protein, helicase Twinkle (TWNK) and the large ribosomal subunit protein bL32m. bL32m is protected from degradation by LONP1 when it is bound to a nucleic acid (RNA), but TWNK is not (PubMed:17579211, PubMed:28377575). {ECO:0000255|HAMAP-Rule:MF_03120, ECO:0000269|PubMed:12198491, ECO:0000269|PubMed:15870080, ECO:0000269|PubMed:17420247, ECO:0000269|PubMed:17579211, ECO:0000269|PubMed:28377575, ECO:0000269|PubMed:8248235}.;
- Disease
- DISEASE: CODAS syndrome (CODASS) [MIM:600373]: A rare syndrome characterized by the combination of cerebral, ocular, dental, auricular, and skeletal features. These include developmental delay, craniofacial anomalies, cataracts, ptosis, median nasal groove, delayed tooth eruption, hearing loss, short stature, delayed epiphyseal ossification, metaphyseal hip dysplasia, and vertebral coronal clefts. {ECO:0000269|PubMed:25574826, ECO:0000269|PubMed:25808063}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.425
Intolerance Scores
- LoFtool
- 0.135
- RVIS EVS
- -1.82
- RVIS percentile EVS
- 2.14
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.964
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |